DrugPatentWatch Database Preview
Drugs in MeSH Category Antirheumatic Agents
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Antares Pharma Inc | OTREXUP PFS | methotrexate | SOLUTION;SUBCUTANEOUS | 204824-010 | May 31, 2017 | DISCN | Yes | No | Start Trial | Start Trial | Start Trial | ||||
Novartis | SANDIMMUNE | cyclosporine | CAPSULE;ORAL | 050625-002 | Mar 2, 1990 | AB2 | RX | Yes | Yes | Start Trial | Start Trial | Start Trial | |||
Antares Pharma Inc | OTREXUP | methotrexate | SOLUTION;SUBCUTANEOUS | 204824-003 | Oct 11, 2013 | RX | Yes | Yes | Start Trial | Start Trial | Y | Start Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |